{
  "paper_id": "PMC7952414",
  "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952414/",
  "figures": {
    "figure_1": {
      "figure_number": "Figure 1",
      "title": "Figure 1.",
      "caption": "TNFAIP8 expression is upregulated in BCC, SCC, and melanoma patient skin tissues. (A) Relative immunohistochemical TNFAIP8 expression in indicated skin cancer tissues is presented. (B) Immunohistochemical expression levels of TNFAIP8 protein from normal skin (n = 6), BCC (n = 6), H-SCC (n = 4), M-SCC (n = 4), L-SCC (n = 4), nevus (n = 6), and melanoma (n = 6) tissues were quantified using ImageJ software (https://imagej.nih.gov/ij/) and plotted. The data represent mean ± SEM from 4 to 6 skin cancer tissues. *P < 0.05 relative to normal skin tissues. (C) Expression of TNFAIP8 transcripts between cutaneous melanoma (n = 45) and melanoma precursor (n = 18) samples were analyzed and presented from the Oncomine dataset (https://www.oncomine.org/resource/login.html accessed October 17, 2020). ***P < 0.001 relatives to cutaneous melanoma tissues. (D, E) Expression of wild-type B-RAF, mutant B-RAFV600E, and TNFAIP8 in HaCaT, SK-MEL-2, A431, A375, and A2058 cells were analyzed by western blotting. Fifty micrograms of lysates from normal and skin cancer cells were immunoblotted with B-RAF, TNFAIP8, GAPDH, and β-actin antibodies. Immunoreactive bands were visualized using ECL chemiluminescence detection reagents after exposing the blots on X-ray films (D) or by scanning the blots with an Odyssey CLx Imager (E). The immunoblot scans were converted into grayscale and presented. (F) Expression of TNFAIP8 mRNA from indicated normal skin cells and skin cancer cells were analyzed by RT/qPCR as described in the “Materials and methods” section.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e45a/7952414/4cb27ccb6e34/41598_2021_85097_Fig1_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e45a/7952414/4cb27ccb6e34/41598_2021_85097_Fig1_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e45a/7952414/4cb27ccb6e34/41598_2021_85097_Fig1_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e45a/7952414/4cb27ccb6e34/41598_2021_85097_Fig1_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig1",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e45a/7952414/4cb27ccb6e34/41598_2021_85097_Fig1_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC7952414/images/figure_1.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e45a/7952414/4cb27ccb6e34/41598_2021_85097_Fig1_HTML.jpg"
    },
    "figure_2": {
      "figure_number": "Figure 2",
      "title": "Figure 2.",
      "caption": "TNFα-induced TNFAIP8 expression in skin cancer cells (A) Schematic represents TNFAIP8 isoform-specific forward and reverse primer design. (B) The expression of different variants/isoforms of TNFAIP8 in normal HaCaT and skin cancer cells was analyzed by RT-PCR. NC–negative control (no cDNA). (C) HaCaT, A431, A375, and A2058 cells were treated with vehicle or TNFα (10–50 ng/ml) for 30 h, and cell lysates were immunoblotted with TNFAIP8 or β-actin antibodies. Immunoreactive bands were visualized using ECL chemiluminescence detection reagents and the blots were scanned using an Odyssey CLx imager. The immunoblot scans were converted into grayscale and presented. (D) Similarly, normal and skin cancer cells were treated with vehicle or TNFα (10-50 ng/ml) for 30 h, and TNFAIP8 mRNA expression was analyzed by RT/qPCR as described in the “Materials and methods” section. *P < 0.05, **P < 0.01, ***P < 0.001 relative to control/vehicle-treated cells. (E) HaCaT, A431, A375 and, A2058 cells were treated with vehicle or TNFα (10–50 ng/ml) for 48 h and, relative cell survival was analyzed by MTT assay as described in the “Materials and methods” section. Results are representative of three independent experiments. *P < 0.05, ***P < 0.001 relative to control/vehicle-treated cells.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e45a/7952414/796cb6102eed/41598_2021_85097_Fig2_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e45a/7952414/796cb6102eed/41598_2021_85097_Fig2_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e45a/7952414/796cb6102eed/41598_2021_85097_Fig2_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e45a/7952414/796cb6102eed/41598_2021_85097_Fig2_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig2",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e45a/7952414/796cb6102eed/41598_2021_85097_Fig2_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC7952414/images/figure_2.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e45a/7952414/796cb6102eed/41598_2021_85097_Fig2_HTML.jpg"
    },
    "figure_3": {
      "figure_number": "Figure 3",
      "title": "Figure 3.",
      "caption": "TNFAIP8 regulates cell proliferation and migration in skin cancer cells. (A) Western blotting analysis of TNFAIP8-Myc tagged protein expression in HaCaT and skin cancer cells. Immunoreactive bands were developed using ECL chemiluminescence detection reagents and the blots were scanned using an Odyssey CLx imager. The immunoblot scans were converted into grayscale and presented. (B) Effect of TNFAIP8-Myc protein overexpression on HaCaT, A431, A375 and, A2058 on cell survival was measured by MTT assay. Results are representative of three independent experiments. *P < 0.05 relative to EV transfected cells. (C) The effect of overexpression of TNFAIP8-Myc on cell colony formation was analyzed and plotted (upper and lower panels) as described in the “Materials and methods” section. *P < 0.05 relative to EV transfected cells. (D) HaCaT, A431, A375 and, A2058 cells were transfected with control siRNA or TNFAIP8 siRNA (100 nM) for 30 h, and cell lysates were western blotted with anti-TNFAIP8 and β-actin antibodies. Western blots were developed using ECL chemiluminescence detection reagents and the blots were scanned using an Odyssey CLx imager. The immunoblot scans were converted into grayscale and presented. TNFAIP8 and β-actin protein levels were quantified using ImageJ software (https://imagej.nih.gov/ij/) and presented below. (E) The effect of TNFAIP8 knockdown by siRNA on cell survival was analyzed by MTT assay. The experiments were independently performed three times. *P < 0.05 relative to control siRNA transfected cells. (F) Control siRNA and TNFAIP8 siRNA-transfected HaCaT, A431, A375 and A2058 cells (3000 cells/well) were re-plated in 6-well plates in triplicate for 7–10 days and skin cancer cell colony formation was analyzed and plotted (upper and lower panels) as described in the “Materials and methods” section. *P < 0.05 relative to control siRNA transfected cells. (G) Wound healing assay: HaCaT, A431, A375 and A2058 cells were transfected with control siRNA or TNFAIP8 siRNA for 48 h. The effect of the TNFAIP8 knockdown on cell migration was analyzed using the wound healing assay. Representative images of the wound healing assay (top) and the calculated scratch area (bottom) are shown. *P < 0.05 relative to control siRNA transfected cells.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e45a/7952414/623fcc7b5dd8/41598_2021_85097_Fig3_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e45a/7952414/623fcc7b5dd8/41598_2021_85097_Fig3_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e45a/7952414/623fcc7b5dd8/41598_2021_85097_Fig3_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e45a/7952414/623fcc7b5dd8/41598_2021_85097_Fig3_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig3",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e45a/7952414/623fcc7b5dd8/41598_2021_85097_Fig3_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC7952414/images/figure_3.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e45a/7952414/623fcc7b5dd8/41598_2021_85097_Fig3_HTML.jpg"
    },
    "figure_4": {
      "figure_number": "Figure 4",
      "title": "Figure 4.",
      "caption": "miR-205-5p targets the 3′UTR of TNFAIP8 and inhibits TNFAIP8 expression. (A) The binding site of miR-205-5p in the 3′UTR of TNFAIP8 was analyzed by TargetScan (http://www.targetscan.org/vert_72/) and presented. We also generated a wild type and mutated binding nucleotides of miR-205-5p to the 3′UTR of TNFAIP8. Wild-type miR-205-5p and mutant miR-205-5p mimics are shown. (B) Relative expression of miR-205-5p in HaCaT, A431, A375, A2058, and SK-MEL-2 cell lines was analyzed by RT/qPCR as described in the “Materials and methods” section. (C) Luciferase reporter assay: A431 and A2058 cells were transfected with TNFAIP8-3′UTR-Luciferase reporter construct (0.5 µg) for 18 h and then transfected with NC mimic or wild-type miR-205-5p mimic or mutant miR-205-5p mimic for an additional 24 h. Transfected cells were lysed, and luciferase activity was measured. Results are representative of two independent experiments. **P < 0.01, ***P < 0.001 compared with NC or mutant-type miR-205-5p mimic. (D, E) Normal or skin cancer cells were transfected with NC or miR-205-5p mimic for 48 h and the overexpression of miR-205-5p mimic and TNFAIP8 transcripts were analyzed by RT/qPCR. ***P < 0.001 compared with NC-transfected cells. *P < 0.05 compared with NC-transfected cells. ns-no significance. (F) HaCaT, A431 and A2058 cell lines were transfected with NC mimic or miR-205-5p mimic for 40 h and expression of endogenous TNFAIP8 protein were analyzed by western blotting. Western blots were developed using ECL chemiluminescence detection reagents, the blots were exposed to X-Ray films, scans were converted into grayscale and presented. (G) HaCaT, 431 and A2058 cell lines were grown on a coverslip and transfected with Cy3-labeled NC mimic or Cy3-labeled miR-205-5p mimic and the effect of Cy3-labeled miR-205-5p mimic on endogenous TNFAIP8 expression (green) was visualized by immunofluorescence as described in the “Materials and methods” section.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e45a/7952414/7f087b6eb39d/41598_2021_85097_Fig4_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e45a/7952414/7f087b6eb39d/41598_2021_85097_Fig4_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e45a/7952414/7f087b6eb39d/41598_2021_85097_Fig4_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e45a/7952414/7f087b6eb39d/41598_2021_85097_Fig4_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig4",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e45a/7952414/7f087b6eb39d/41598_2021_85097_Fig4_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC7952414/images/figure_4.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e45a/7952414/7f087b6eb39d/41598_2021_85097_Fig4_HTML.jpg"
    },
    "figure_5": {
      "figure_number": "Figure 5",
      "title": "Figure 5.",
      "caption": "miR-205-5p targets TNFAIP8 and reduces TNFAIP8-mediated cell proliferation and autophagy. (A) HaCaT, A431 and A2058 cells were transfected with NC mimic or miR-205-5p mimic for 48 h and relative cell survival was analyzed by MTT assay. The experiments were independently repeated three times. *P < 0.05 compared with NC mimic transfected cells. (B) NC mimic or miR-205-5p mimic transfected cells were re-plated in 6-well plates for 7–10 days and cell colony formation was analyzed and plotted (upper and lower panels) as described in the “Materials and methods” section. The experiment was repeated twice in triplicates. *P < 0.05 relative to NC mimic transfected cells. (C) HaCaT, A431 and A2058 cells were transfected EV or TNFAIP8-Myc plasmids for 30 h and lysates were western blotted with anti-Myc, anti-LC3β I/II, and anti-β-actin antibodies. Western blots were developed using ECL chemiluminescence detection reagents, the blots were exposed on X-ray films, converted into grayscale, and presented. (D) HaCaT, lanoma A431 and A2058 cells were transfected NC mimic or miR-205-5p mimic for 30 h and lysates were western blotted with anti-TNFAIP8, anti-LC3β I/II, anti-p62, and anti-β-actin antibodies. Western blots were developed using ECL chemiluminescence detection reagents, exposed on X-Ray films, converted into grayscale, and presented. (E) HaCaT, A431 and A2058 cells were grown on a coverslip transfected with Cy3-labeled NC mimic or Cy3-labeled miR-205-5p mimic and the effect of Cy3-labeled miR-205-5p mimic on endogenous LC3β I/II expression (green) and related puncta formation were visualized by immunofluorescence (upper panels) as described in the “Materials and methods” section (upper panel). LC3β I/II and related puncta were measured from individual cells (n = 10) and plotted (lower panels). **P < 0.01, ***P < 0.001 relatives to Cy3 labeled-NC mimic transfected cells.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e45a/7952414/7a3b26b17448/41598_2021_85097_Fig5_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e45a/7952414/7a3b26b17448/41598_2021_85097_Fig5_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e45a/7952414/7a3b26b17448/41598_2021_85097_Fig5_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e45a/7952414/7a3b26b17448/41598_2021_85097_Fig5_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig5",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e45a/7952414/7a3b26b17448/41598_2021_85097_Fig5_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC7952414/images/figure_5.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e45a/7952414/7a3b26b17448/41598_2021_85097_Fig5_HTML.jpg"
    },
    "figure_6": {
      "figure_number": "Figure 6",
      "title": "Figure 6.",
      "caption": "miR-205-5p targets TNFAIP8 in skin cancer cells and increase sensitivity to vemurafenib. (A) HaCaT cells, and skin cancer SK-MEL-2, A375 and A2058 cell lines were treated with increasing concentrations of vemurafenib for 48 h and relative cell survival/proliferation was measured by MTT assay. The experiments were independently repeated three times. **P < 0.01, ***P < 0.001 compared to vehicle-treated cells. (B) HaCaT cells and skin cancer SK-MEL-2, A375 and A2058 cell lines were transfected with NC mimic or miR-205-5p mimic for 24 h and treated with vemurafenib or vehicle for an additional 48 h and relative cell survival were measured by MTT assay as described in the “Materials and methods” section. *P < 0.05, **P < 0.01, ***P < 0.001 compared to NC mimic vehicle-treated cells or NC mimic and vemurafenib-treated cells. ns-no significance. (C) Melanoma A375 cells were transfected with NC mimic or miR-205-5p mimic for 18 h and then cells were treated with vemurafenib for an additional 24 h. Fifty micrograms of lysates were immunoblotted with anti-cleaved-PARP and anti-β-tubulin antibodies. Western blots were developed using ECL chemiluminescence detection reagents, the blots were scanned using Azure C-500 Biosystem, scans were converted into grayscale and presented. (D) Melanoma A375 cells were transfected with EV of TNFAIP8-Myc plasmid for 18 h first and then cells were treated with vemurafenib or paclitaxel for 24 h as indicated and fifty micrograms lysates were immunoblotted with anti-Myc, anti-cleaved-PARP, and anti-β-actin antibodies. Western blots were developed using ECL chemiluminescence detection reagents and the blots were scanned using an Odyssey CLx imager. The immunoblot scans were converted into grayscale and presented. (E) Fifty micrograms of lysates from A375 and A2058 cells or A375R and A2058R (vemurafenib resistant) cells were immunoblotted with anti-TNFAIP8, anti-LC3β I/II, and anti-β-actin antibodies. Western blots were developed using ECL chemiluminescence detection reagents, the blots were exposed on X-Ray films, scans were converted into grayscale and presented. (F) Relative cell proliferation/cell survival rate of A375 and A2058 cells, or A375R and A2058R (vemurafenib resistant) cells were measured by using WST-1 reagent (Cayman Chemical) (upper panel) or MTT assay reagent (lower panel) and plotted. **P < 0.01, ***P < 0.001 compared to A375 and A2058 parent cells. Results are representative of three independent experiments. Vem. Vemurafenib.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e45a/7952414/09d0123d7efa/41598_2021_85097_Fig6_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e45a/7952414/09d0123d7efa/41598_2021_85097_Fig6_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e45a/7952414/09d0123d7efa/41598_2021_85097_Fig6_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e45a/7952414/09d0123d7efa/41598_2021_85097_Fig6_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig6",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e45a/7952414/09d0123d7efa/41598_2021_85097_Fig6_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC7952414/images/figure_6.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e45a/7952414/09d0123d7efa/41598_2021_85097_Fig6_HTML.jpg"
    }
  },
  "claims": [
    {
      "sentence": "The expression of TNFAIP8 was found to be significantly increased in BCC (n = 6) and low/medium differentiated SCC tissue (n = 4) compared with normal skin tissues (n = 6) (Fig. 1A,B).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel A",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Interestingly, the expression of TNFAIP8 was significantly increased (~ two fold) in melanoma tissues compared with normal skin tissues (Fig. 1A,B).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel A",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Also, we analyzed the TNFAIP8 mRNA expression between cutaneous melanoma (n = 45) and melanoma precursor (n = 18) samples as reported in the Oncomine dataset (https://www.oncomine.org/resource/login.html accessed October 17, 2020)48 (Fig. 1C).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel C",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel C",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel C",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The data suggest that the expression of TNFAIP8 transcripts is 2.55-fold higher in melanoma precursor tissues compared with cutaneous melanoma (Fig. 1C).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel C",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel C",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel C",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "First, we analyzed the expression of B-RAF wild and B-RAFV600E mutant proteins in these cell lines (Fig. 1D).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel D",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel D",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel D",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Consistent with earlier reports, immunoblotting data from our laboratory indicate that all the skin cancer cell lines and normal skin cells used in this study expressed moderate levels of either B-RAF wild-type protein in HaCaT, A431, SK-MEL-2 cells, or B-RAFV600E mutant protein in A375 and A2058 cells (Fig. 1D)49,50.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel D",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel D",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel D",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Further, we analyzed the expression of TNFAIP8 protein and transcripts in normal skin cells and B-RAF wild type or B-RAFV600E mutant skin cancer cells (Fig. 1E,F).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel E",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Immunoblotting and RT/qPCR data demonstrated that TNFAIP8 expression was higher in SK-MEL-2 (melanoma cells), A431 (SCC cells), and HaCaT (normal skin cells) which express B-RAF wild type protein, and lower expression of TNFAIP8 was observed in A375 and A2058 melanoma cells that expressed B-RAFV600E mutant protein (Fig. 1E,F).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel E",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The expression of TNFAIP8 was found to be significantly increased in BCC (n = 6) and low/medium differentiated SCC tissue (n = 4) compared with normal skin tissues (n = 6) (Fig. 1A,B).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel A",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Interestingly, the expression of TNFAIP8 was significantly increased (~ two fold) in melanoma tissues compared with normal skin tissues (Fig. 1A,B).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel A",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Also, we analyzed the TNFAIP8 mRNA expression between cutaneous melanoma (n = 45) and melanoma precursor (n = 18) samples as reported in the Oncomine dataset (https://www.oncomine.org/resource/login.html accessed October 17, 2020)48 (Fig. 1C).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel C",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel C",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel C",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The data suggest that the expression of TNFAIP8 transcripts is 2.55-fold higher in melanoma precursor tissues compared with cutaneous melanoma (Fig. 1C).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel C",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel C",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel C",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "First, we analyzed the expression of B-RAF wild and B-RAFV600E mutant proteins in these cell lines (Fig. 1D).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel D",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel D",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel D",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Consistent with earlier reports, immunoblotting data from our laboratory indicate that all the skin cancer cell lines and normal skin cells used in this study expressed moderate levels of either B-RAF wild-type protein in HaCaT, A431, SK-MEL-2 cells, or B-RAFV600E mutant protein in A375 and A2058 cells (Fig. 1D)49,50.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel D",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel D",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel D",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Further, we analyzed the expression of TNFAIP8 protein and transcripts in normal skin cells and B-RAF wild type or B-RAFV600E mutant skin cancer cells (Fig. 1E,F).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel E",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Immunoblotting and RT/qPCR data demonstrated that TNFAIP8 expression was higher in SK-MEL-2 (melanoma cells), A431 (SCC cells), and HaCaT (normal skin cells) which express B-RAF wild type protein, and lower expression of TNFAIP8 was observed in A375 and A2058 melanoma cells that expressed B-RAFV600E mutant protein (Fig. 1E,F).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel E",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Reports also suggest that TNFAIP8 gene expressed several protein variants/isoforms in cancer cell lines34,35, and therefore first we analyzed the expression TNFAIP8 isoforms in normal and skin cancer cells by RT/PCR (Fig. 2A,B).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Normal HaCaT cells, A431, A375, A2058 cells expressed isoform one, whereas expression of isoform one is not observed in SK-MEL-2 cells suggesting that, skin cancer cells expressed isoform two predominantly (Fig. 2B) and the involvement of TNFAIP8 variant/isoform 2 in lung cancer and liver cancer development and progression has been reported earlier37,43.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Overexpression of TNFAIP8 increases skin cancer cell survival, colony formation and migration\nTo clarify the exact role of TNFAIP8 in skin cancer cell proliferation, we transiently transfected normal HaCaT skin cells and A431, A375, and A2058 skin cancer cells with empty vector (EV) or TNFAIP8-Myc plasmid (Fig. 3A).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Immunoblotting data demonstrated the overexpression of TNFAIP8-Myc tagged protein in cells transfected with TNFAIP8-Myc tagged plasmid but not in an empty vector (EV) transfected cells (Fig. 3A).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The MTT assay demonstrated that overexpression of TNFAIP8 increased cell survival significantly; by ~ 55%, 82%, 68% in A431, A375, and A2058 skin cancer cells, respectively (Fig. 3B).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "However, no significant effect on cell survival/proliferation was observed in HaCaT normal skin cells transfected with TNFAIP8 (Fig. 3B).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "TNFAIP8 expression promoted cell colony formation in A431 cells by 3.1-fold, A375 cells by 4.2-fold, and A2058 cells by 5.1-fold compared with empty vector-transfected cells (Fig. 3C, upper and lower panels).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Similarly, no significant effect of TNFAIP8 overexpression on cell colony formation was observed in normal skin HaCaT cells (Fig. 3C, upper and lower panels).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Representative images of the wound healing assay (top) and the calculated scratch area (bottom) are shown. *P < 0.05 relative to control siRNA transfected cells.In parallel, we used siRNA to knockdown endogenous TNFAIP8 protein in normal and skin cancer cells (Fig. 3D).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel D",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel D",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel D",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Transfection of TNFAIP8 siRNA significantly reduced endogenous TNFAIP8 levels in all cell lines compared with the control siRNA transfected cells (Fig. 3D).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel D",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel D",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel D",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "MTT assay demonstrated that TNFAIP8 knockdown reduced cell survival in A431 cells by 22%, in A375 cells by 55.2%, and in A2058 cells by 45.3% compared with control siRNA transfected cells (Fig. 3E).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel E",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel E",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel E",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Similarly, TNFAIP8 knockdown also significantly decreased cell colony formation ability in A431 cells by 18.4%, in A375 cells by 53.2%, and in A2058 cells by 40.3% compared with control siRNA transfected cells (Fig. 3F, upper and lower panels).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel F",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The wound healing migration assay revealed that TNFAIP8 knockdown significantly inhibited cell migration and wound closure in A431 (15.1%), A375 (52.5%), and A2058 (70.4%) compared with control siRNA transfected cells (Fig. 3G, upper and lower panels).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel G",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "In contrast, no significant effects on cell survival, cell colony formation, and migration were observed in HaCaT cells transfected with TNFAIP8 siRNA compared with control siRNA transfected cells (Fig. 3E–G).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel E",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Indeed, the data presented in Fig. 3 suggests that TNFAIP8 promotes cell proliferation and cell migration in skin cancer cells.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "To clarify the exact role of TNFAIP8 in skin cancer cell proliferation, we transiently transfected normal HaCaT skin cells and A431, A375, and A2058 skin cancer cells with empty vector (EV) or TNFAIP8-Myc plasmid (Fig. 3A).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Immunoblotting data demonstrated the overexpression of TNFAIP8-Myc tagged protein in cells transfected with TNFAIP8-Myc tagged plasmid but not in an empty vector (EV) transfected cells (Fig. 3A).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The MTT assay demonstrated that overexpression of TNFAIP8 increased cell survival significantly; by ~ 55%, 82%, 68% in A431, A375, and A2058 skin cancer cells, respectively (Fig. 3B).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "However, no significant effect on cell survival/proliferation was observed in HaCaT normal skin cells transfected with TNFAIP8 (Fig. 3B).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "TNFAIP8 expression promoted cell colony formation in A431 cells by 3.1-fold, A375 cells by 4.2-fold, and A2058 cells by 5.1-fold compared with empty vector-transfected cells (Fig. 3C, upper and lower panels).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Similarly, no significant effect of TNFAIP8 overexpression on cell colony formation was observed in normal skin HaCaT cells (Fig. 3C, upper and lower panels).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "In parallel, we used siRNA to knockdown endogenous TNFAIP8 protein in normal and skin cancer cells (Fig. 3D).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel D",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel D",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel D",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Transfection of TNFAIP8 siRNA significantly reduced endogenous TNFAIP8 levels in all cell lines compared with the control siRNA transfected cells (Fig. 3D).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel D",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel D",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel D",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "MTT assay demonstrated that TNFAIP8 knockdown reduced cell survival in A431 cells by 22%, in A375 cells by 55.2%, and in A2058 cells by 45.3% compared with control siRNA transfected cells (Fig. 3E).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel E",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel E",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel E",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Similarly, TNFAIP8 knockdown also significantly decreased cell colony formation ability in A431 cells by 18.4%, in A375 cells by 53.2%, and in A2058 cells by 40.3% compared with control siRNA transfected cells (Fig. 3F, upper and lower panels).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel F",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The wound healing migration assay revealed that TNFAIP8 knockdown significantly inhibited cell migration and wound closure in A431 (15.1%), A375 (52.5%), and A2058 (70.4%) compared with control siRNA transfected cells (Fig. 3G, upper and lower panels).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel G",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "In contrast, no significant effects on cell survival, cell colony formation, and migration were observed in HaCaT cells transfected with TNFAIP8 siRNA compared with control siRNA transfected cells (Fig. 3E–G).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel E",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Indeed, the data presented in Fig. 3 suggests that TNFAIP8 promotes cell proliferation and cell migration in skin cancer cells.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "TargetScan analysis revealed that miR-205-5p is predicted to bind with the 3′ UTR of TNFAIP8 gene (61–68) (Fig. 4A).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel A",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel A",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel A",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "RT/qPCR data showed that miR-205-5p expression was higher in HaCaT cells and SCC-A431 cells, whereas, the expression of miR-205-5p was not detected in melanoma A375, A2058, and SK-MEL-2 (Fig. 4B).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "The data showed that the miR-205-5p mimic significantly inhibited luciferase activity compared with negative control (NC) or mutant miR-205-5p mimic transfected both cell lines (Fig. 4C).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel C",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel C",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel C",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Overexpression of miR-205 mimic in HaCaT, A431, and A2058 cell lines was analyzed by RT/qPCR (Fig. 4D).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel D",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel D",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel D",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Overexpression of miR-205-5p mimic significantly decreased both TNFAIP8 mRNA and protein expression in HaCaT, A431 and A2058 cell lines (Fig. 4E,F).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel E",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "We also performed immunocytochemistry and analyzed endogenous TNFAIP8 protein expression by immunofluorescence after delivery of Cy3 labeled miR-205-5p or Cy3 labeled NC mimic into HaCaT, A431 and A2058 cells (Fig. 4G).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel G",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel G",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel G",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "TNFAIP8 immunofluorescence data suggest that transfection of Cy3-miR-205-5p in all three cell lines decreased cytosolic TNFAIP8-associated fluorescence (merge panel) compared with Cy3-labeled-NC mimic transfected cells (Fig. 4G) suggesting that miR-205-5p targets the TNFAIP8-3′UTR and inhibits TNFAIP8 protein expression.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel G",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel G",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel G",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "TargetScan analysis revealed that miR-205-5p is predicted to bind with the 3′ UTR of TNFAIP8 gene (61–68) (Fig. 4A).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel A",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel A",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel A",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "RT/qPCR data showed that miR-205-5p expression was higher in HaCaT cells and SCC-A431 cells, whereas, the expression of miR-205-5p was not detected in melanoma A375, A2058, and SK-MEL-2 (Fig. 4B).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "The data showed that the miR-205-5p mimic significantly inhibited luciferase activity compared with negative control (NC) or mutant miR-205-5p mimic transfected both cell lines (Fig. 4C).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel C",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel C",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel C",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Overexpression of miR-205 mimic in HaCaT, A431, and A2058 cell lines was analyzed by RT/qPCR (Fig. 4D).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel D",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel D",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel D",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Overexpression of miR-205-5p mimic significantly decreased both TNFAIP8 mRNA and protein expression in HaCaT, A431 and A2058 cell lines (Fig. 4E,F).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel E",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "We also performed immunocytochemistry and analyzed endogenous TNFAIP8 protein expression by immunofluorescence after delivery of Cy3 labeled miR-205-5p or Cy3 labeled NC mimic into HaCaT, A431 and A2058 cells (Fig. 4G).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel G",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel G",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel G",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "TNFAIP8 immunofluorescence data suggest that transfection of Cy3-miR-205-5p in all three cell lines decreased cytosolic TNFAIP8-associated fluorescence (merge panel) compared with Cy3-labeled-NC mimic transfected cells (Fig. 4G) suggesting that miR-205-5p targets the TNFAIP8-3′UTR and inhibits TNFAIP8 protein expression.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel G",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel G",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel G",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "No significant effect on cell proliferation/survival was observed in HaCaT cells transfected of miR-205-5p or the NC mimic control, however, a significant decrease in cell proliferation was observed in A431 and A2058 cell lines (Fig. 5A).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel A",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel A",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel A",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Also, we analyzed the effect of miR-205-5p on cell colony formation in normal skin cell line HaCaT, and A431 and A2058 cell lines (Fig. 5B).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel B",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel B",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel B",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Similar to the effects were seen in the cell survival assay, transfection with miR-205-5p mimic or the NC mimic control did not affect cell colony formation in HaCaT cells (Fig. 5B, left panel).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel B",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Interestingly, cell colony formation was decreased by 32.5% in A431 cells and 38.5% in A2058 cells when cells were transfected with miR-205-5p compared with NC transfected cells (Fig. 5B, middle and right panels).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel B",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Consistent with these findings, we demonstrate here that overexpression of TNFAIP8 also induced autophagy in HaCaT, A431, and A2058 cell lines based on induction of autophagy bio-marker LC3β II (Fig. 5C).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel C",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel C",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel C",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Conversely, inhibition of TNFAIP8 expression by miR-205-5p mimic decreased autophagy biomarkers LC3β II and p62 expression in A431 and A2058 cells compared with NC mimic control transfected cells (Fig. 5D).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel D",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel D",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel D",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Immunocytochemistry data showed that miR-205-5p mimic transfection significantly decreased LC3β related puncta formation in A431 and A2058 cells as well as in HaCaT cells (Fig. 5E, upper and lower panels) suggesting that miR-205-5p inhibits cell proliferation and TNFAIP8-mediated autophagy induction in skin cancer cells.",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel E",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "No significant effect on cell proliferation/survival was observed in HaCaT cells transfected of miR-205-5p or the NC mimic control, however, a significant decrease in cell proliferation was observed in A431 and A2058 cell lines (Fig. 5A).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel A",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel A",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel A",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Also, we analyzed the effect of miR-205-5p on cell colony formation in normal skin cell line HaCaT, and A431 and A2058 cell lines (Fig. 5B).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel B",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel B",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel B",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Similar to the effects were seen in the cell survival assay, transfection with miR-205-5p mimic or the NC mimic control did not affect cell colony formation in HaCaT cells (Fig. 5B, left panel).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel B",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Interestingly, cell colony formation was decreased by 32.5% in A431 cells and 38.5% in A2058 cells when cells were transfected with miR-205-5p compared with NC transfected cells (Fig. 5B, middle and right panels).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel B",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Consistent with these findings, we demonstrate here that overexpression of TNFAIP8 also induced autophagy in HaCaT, A431, and A2058 cell lines based on induction of autophagy bio-marker LC3β II (Fig. 5C).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel C",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel C",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel C",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Conversely, inhibition of TNFAIP8 expression by miR-205-5p mimic decreased autophagy biomarkers LC3β II and p62 expression in A431 and A2058 cells compared with NC mimic control transfected cells (Fig. 5D).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel D",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel D",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel D",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Immunocytochemistry data showed that miR-205-5p mimic transfection significantly decreased LC3β related puncta formation in A431 and A2058 cells as well as in HaCaT cells (Fig. 5E, upper and lower panels) suggesting that miR-205-5p inhibits cell proliferation and TNFAIP8-mediated autophagy induction in skin cancer cells.",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel E",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "We treated HaCaT and SK-MEL-2 cells which possess wild type B-RAF protein, and A375 and A2058 cells which express mutant B-RAFV600E with vemurafenib and relative drug sensitivity were analyzed by cell survival MTT assay (Fig. 6A).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel A",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel A",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel A",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Consistent with the clinical data, a dose-dependent treatment of vemurafenib (0.1–25 µM) decreased cell survival in A375 and A2058 which possesses B-RAFV600E mutant, whereas, SK-MEL-2 cells and HaCAT cell lines which express wild type B-RAF protein showed significant resistance to vemurafenib (Fig. 6A).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel A",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel A",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel A",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Vemurafenib.Since the expression miR-205-5p was not detected in melanoma A375 and A2058 cell lines (Fig. 4B), and miR-205-5p targets TNFAIP8, we further examined the potential role of miR-205-5p in vemurafenib sensitivity.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "We transfected normal and skin cancer cells with miR-205-5p and treated with vemurafenib as indicated and relative drug sensitivity was analyzed (Fig. 6B).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel B",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel B",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel B",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Compared with control NC mimic transfected cells, miR-205-5p transfection alone decreased cell survival in A375, and A2058 cells but not in HaCaT or SK-MEL-2 cells significantly (Fig. 6B).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel B",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel B",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel B",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Transfection with miR-205-5p and treatment with vemurafenib further decreased cell survival compared with vemurafenib alone in skin cancer lines SK-MEL-2, A375, and A2058 cells (Fig. 6B, left and right panels).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel B",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Thus, by targeting TNFAIP8, miR-205-5p could further increase drug sensitivity in the B-RAFV600E mutant melanoma cell lines (Fig. 6B).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel B",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel B",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel B",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Moreover, transfection of miR-205-5p in A375 (B-RAFV600E mutant) cells induced the expression of cell apoptotic marker cPARP compared with NC mimic transfected cells (Fig. 6C, lane 1 & 2).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel C",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Furthermore, transfection of miR-205-5p combined with vemurafenib treatment increased cPARP expression compared with NC mimic transfected and vemurafenib treated cells (Fig. 6C, lane 3 & 4).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel C",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "On the other hand, overexpression of TNFAIP8 decreased paclitaxel and vemurafenib-mediated cPARP expression compared with EV transfected A375 cells (Fig. 6D, compare lanes 1–3 and 4–6).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel D",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "A higher expression of TNFAIP8, autophagy marker LB3β II, and increased cell proliferation were observed in A375R or A2058R vemurafenib drug-resistant cells compared with parent A375 or A2058 melanoma cells (Fig. 6E,F).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel E",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Collectively the data presented in Fig. 6 suggest that (A) expression of miR-205-5p in melanoma cells increases sensitivity towards vemurafenib particularly in B-RAFV600E mutant cells (B) increased expression of TNFAIP8 reduces drug-mediated cell apoptosis, and (C) increased expression of TNFAIP8 due to vemurafenib drug-resistance increases autophagy and cell proliferation.",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "We treated HaCaT and SK-MEL-2 cells which possess wild type B-RAF protein, and A375 and A2058 cells which express mutant B-RAFV600E with vemurafenib and relative drug sensitivity were analyzed by cell survival MTT assay (Fig. 6A).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel A",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel A",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel A",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Consistent with the clinical data, a dose-dependent treatment of vemurafenib (0.1–25 µM) decreased cell survival in A375 and A2058 which possesses B-RAFV600E mutant, whereas, SK-MEL-2 cells and HaCAT cell lines which express wild type B-RAF protein showed significant resistance to vemurafenib (Fig. 6A).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel A",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel A",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel A",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Since the expression miR-205-5p was not detected in melanoma A375 and A2058 cell lines (Fig. 4B), and miR-205-5p targets TNFAIP8, we further examined the potential role of miR-205-5p in vemurafenib sensitivity.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel B",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "We transfected normal and skin cancer cells with miR-205-5p and treated with vemurafenib as indicated and relative drug sensitivity was analyzed (Fig. 6B).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel B",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel B",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel B",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Compared with control NC mimic transfected cells, miR-205-5p transfection alone decreased cell survival in A375, and A2058 cells but not in HaCaT or SK-MEL-2 cells significantly (Fig. 6B).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel B",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel B",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel B",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Transfection with miR-205-5p and treatment with vemurafenib further decreased cell survival compared with vemurafenib alone in skin cancer lines SK-MEL-2, A375, and A2058 cells (Fig. 6B, left and right panels).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel B",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Thus, by targeting TNFAIP8, miR-205-5p could further increase drug sensitivity in the B-RAFV600E mutant melanoma cell lines (Fig. 6B).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel B",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel B",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel B",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Moreover, transfection of miR-205-5p in A375 (B-RAFV600E mutant) cells induced the expression of cell apoptotic marker cPARP compared with NC mimic transfected cells (Fig. 6C, lane 1 & 2).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel C",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Furthermore, transfection of miR-205-5p combined with vemurafenib treatment increased cPARP expression compared with NC mimic transfected and vemurafenib treated cells (Fig. 6C, lane 3 & 4).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel C",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "On the other hand, overexpression of TNFAIP8 decreased paclitaxel and vemurafenib-mediated cPARP expression compared with EV transfected A375 cells (Fig. 6D, compare lanes 1–3 and 4–6).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel D",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "A higher expression of TNFAIP8, autophagy marker LB3β II, and increased cell proliferation were observed in A375R or A2058R vemurafenib drug-resistant cells compared with parent A375 or A2058 melanoma cells (Fig. 6E,F).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel E",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Collectively the data presented in Fig. 6 suggest that (A) expression of miR-205-5p in melanoma cells increases sensitivity towards vemurafenib particularly in B-RAFV600E mutant cells (B) increased expression of TNFAIP8 reduces drug-mediated cell apoptosis, and (C) increased expression of TNFAIP8 due to vemurafenib drug-resistance increases autophagy and cell proliferation.",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        }
      ]
    }
  ],
  "extraction_stats": {
    "figures_count": 6,
    "claims_count": 96,
    "images_downloaded": 6,
    "tables_filtered": 48
  }
}